Cargando…

Low-Dose Naltrexone in Rheumatological Diseases

BACKGROUND: Naltrexone has been approved for alcohol and opioid abuse by the FDA. At low-dose naltrexone (LDN) has been used in several diseases including chronic pain and autoimmune conditions, including rheumatic disorders. AIM: To review the use of LDN in rheumatic diseases: systemic sclerosis (S...

Descripción completa

Detalles Bibliográficos
Autores principales: de Carvalho, Jozélio Freire, Skare, Thelma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201089/
https://www.ncbi.nlm.nih.gov/pubmed/37223594
http://dx.doi.org/10.31138/mjr.34.1.1